Validation of structural effects mediated by MR-guided focused ultrasound on animal kidney ex vivo model

Timur Saliev, Ioannis Karakitsios, Sarfraz Ahmad, Stewart Fleming, Andreas Melzer


Introduction: MR-guided Focused Ultrasound (MRgFUS) has attracted the attention of researchers and clinicians as a potential modality for cancer treatment over the last decades. Despite recent progress, the real application of MRgFUS still remains a challenge due to problems with the optimization of ultrasound parameters and standardization of clinical protocol. In this study, we utilized an ex vivo animal model in order to elucidate the effect of focused acoustic energy on kidney tissue.

Material & Methods: The explanted porcine kidney was sonicated under MR-guidance by using a clinical Focused Ultrasound (FUS) system (ExAblate 2000 Body system, InSightec, Haifa, Israel). The study employed MR-based temperature mapping (Proton Resonance Frequency method) for control of the ablation. The data of temperature measurement has been compared to histological analysis of treated tissues.

Results: The temperature mapping data demonstrated a rise of temperature at the focal point up to 440C (SD±1), which was thought to be sufficient enough to trigger hyperthermia effects. Histopathological analysis showed tissue destruction as a result of massive cavitation in treated tissues. The signs of mechanical damage were more pronounced in a place that was treated 240 seconds compared with the first location (sonicated 120 seconds).

Conclusions: The effect of FUS on the tissues of animal kidney was investigated. The achieved level of temperature rise in the focal point was high enough to induce hyperthermia suggesting possible clinical application. Histology of treated tissue indicated that its therapeutic effect was mediated by focused ultrasound. The correlation between duration of sonication and tissue damage was demonstrated.


Full Text:



Journal of Solid Tumors

ISSN 1925-4067(Print)   ISSN 1925-4075(Online)

Copyright © Sciedu Press

To make sure that you can receive messages from us, please add the '' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.